News

Dr Cathy Tralau-Stewart is an experienced therapeutics development scientist and pharmacologist. Working within some of the world’s leading pharma and academic research establishments, she has developed a broad knowledge of drug discovery…

Inaphaea continues to drive innovation in drug development through its cutting-edge work with Patient-Derived Cells (PDCs), advanced in-silico modelling, and strategic collaborations. By partnering with leading academic institutions and industry innovators, Inaphaea…

Inaphaea BioLabs, a pioneering translational research organisation based in Nottingham, has announced a series of strategic collaborations and research advances that significantly strengthen its position at the forefront of personalised cancer therapy…

Inaphaea BioLabs, the wholly owned translational Contract Research Organisation of ValiRx Plc, has announced a series of major initiatives over the past three months that significantly advance its role in translational cancer…

Inaphaea BioLabs, the translational Contract Research Organisation (tCRO) wholly owned by ValiRx Plc, will play a pivotal role in the development of a newly established subsidiary, Blue Ribbon Bio Limited, dedicated to…

Inaphaea BioLabs Limited, the wholly owned subsidiary of ValiRx Plc, specialising in advanced patient-derived cell (PDC) models, has been awarded a Knowledge Transfer Voucher (KTV) by The Open University to support cutting-edge…

Earlier this month, ValiRx Plc, a life science company focused on early-stage cancer therapeutics and women’s health, announced a new 12-month agreement with Stingray Bio Limited (“Stingray”), placing its wholly owned subsidiary,…

Inaphaea is pleased to announce the execution of an exclusive licence agreement with UK-based Dominion Biotech Ltd for Inaphaea’s PredictRx® platform. PredictRx is a personalised cancer screening service whereby a patient’s tumour…

Life science innovation company ValiRx has announced the appointment of a Director of Research and expanded the lab team of its research subsidiary, Inaphaea BioLabs. Michelle Barnard joins ValiRx to head up…

In December, Roy took part in a two-week internship where he was able to gain valuable experience in the Inaphaea labs.  During his internship Roy was able to draw on the skills…